Phio Pharmaceuticals Corp. Total Revenue

• Phio Pharmaceuticals Corp. showed a decrease of -100.0% in Total Revenue from 2019 to 2020.
• This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 25, 2021.
• XBRL data for this metric is available from 2012 to 2020 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2012: $57.0 thousand | Q1 2013: $53.0 thousand | Q2 2013: $225.0 thousand | Q3 2013: $92.0 thousand | Q1 2014: $29.0 thousand | Q1 2015: $34.0 thousand | Q1 2016: $10.0 thousand | Q2 2016: $9.0 thousand | Q2 2017: $0.00 | Q3 2017: $0.00 | Q1 2018: $23.0 thousand | Q2 2018: $58.0 thousand | Q3 2018: $57.0 thousand | Q1 2019: $21.0 thousand | Q2 2019: $0.00 | Q3 2019: $0.00 | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $0.00.
• Over the full 8 years of available data (2012 to 2020), Phio Pharmaceuticals Corp.'s Total Revenue has declined by 100.0%.
• Historical annual values: Fiscal year 2020: $0.00 | Fiscal year 2019: $21.0 thousand | Fiscal year 2018: $138.0 thousand | Fiscal year 2017: $15.0 thousand | Fiscal year 2016: $19.0 thousand | Fiscal year 2015: $34.0 thousand | Fiscal year 2013: $399.0 thousand | Fiscal year 2012: $97.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026